PYXS vs QRVO · rev $2.8M vs P/E 27, rev $3.68B
Pyxis Oncology Inc (PYXS) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
PYXS currently screens at market cap $109.6M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the PYXS and QRVO stock pages for the full models.
Not investment advice.